Peter Attia’s Longevity Framework — Targeting-System Adaptation

TL;DR

• Framework: Attia backsolves longevity from a Centenarian Decathlon (10 specific physical capabilities at 80) and an explicit fight against four causes of death (the Four Horsemen: cardiovascular, cancer, neurodegenerative, metabolic). Everything else is downstream.
• Operationalization: Medicine 3.0 = quantitative early prevention. Instrument biomarkers + capacity tests, dose lifestyle and pharmacology against early signals, re-test on a fixed cadence. The whole thing is a closed-loop control system applied to a single human body.
• Why it fits Ben: This is the targeting-system mindset (sensors / actions / outcomes / feedback) applied to physiology. Attia is more directly transferable to RDCO instrumentation thinking than Sinclair’s molecular-supplements pitch — and significantly less commercially compromised on the protocol layer.

The Centenarian Decathlon

What it is. A backcasting exercise: identify 10 physical tasks you want to perform in your “marginal decade” (roughly 80-90), then reverse-engineer a training prescription that gets you there. The premise: physical capacity decays predictably with age, so whatever you want at 80 you must dramatically over-train for now. Per Attia: “the body, in most people, will fail before the other systems.”

The events (Attia’s own examples — pick 10 personalized to you):

1. Lift a 30 lb suitcase overhead into an overhead bin
2. Carry two 10-lb bags of groceries up three flights of stairs
3. Get up off the floor using only one arm for support
4. Drop into a deep squat and lift a 30 lb child
5. Climb out of a swimming pool without a ladder
6. Hike a steep trail carrying a small grandchild
7. Play with grandchildren on the floor for 30+ min
8. Shoot a bow and arrow (rotational + grip)
9. Walk briskly for an hour without stopping
10. Catch yourself from a fall (reactive stability)

Backsolve logic. If you want to deadlift bodyweight at 85, and decline is roughly 1-2% per year past 50, you need to deadlift ~1.5-2x bodyweight today. Same logic for VO2max, grip, gait speed. Today’s training target is the 80-year-old target plus 30+ years of expected decay.

The Four Horsemen — early signal + intervention lever per disease

These cause >80% of non-smoker deaths over age 50. Attia’s Med 3.0 move is to fight each one a decade before it shows up clinically.

The pattern: he refuses to wait for diagnosis. He treats elevated risk markers as the disease and intervenes on a 10-20 year horizon.

Medicine 3.0 — Attia’s framing

• Med 1.0 — pre-evidence-based; bloodletting, four humors. Pre-1850 medicine.
• Med 2.0 — current evidence-based standard-of-care. Excellent at acute care (trauma, infection, surgery); structurally bad at chronic disease because it waits for diagnosable disease before acting. The whole apparatus is reactive.
• Med 3.0 — quantitative early prevention. Treats risk markers, biomarker drift, and capacity loss as the actual disease. Personalizes intervention on the individual’s biomarker stack rather than population-average guidelines. Tighter feedback loops (quarterly bloodwork, annual VO2max, biennial DEXA + CGM cycles).

Why this is the targeting-system mindset, restated: Med 2.0 is “wait for the alarm, then act.” Med 3.0 is “instrument the system, observe drift, intervene before the alarm.” The targeting-system framing of niche → bottleneck → instrumentation → feedback is the same architecture: identify the chronic disease you’re actually trying to prevent (niche), find the upstream biomarker that signals it 10+ years early (bottleneck), instrument your body for it (sensor), pull the lever you can move (action), re-measure (feedback).

Operationalization — sensors, actions, outcomes, feedback loop

This is the load-bearing section. Recasting Attia’s prescriptions in Ben’s targeting-system language:

Sensors (instrumentation)

• Quarterly-to-annual bloodwork: ApoB, Lp(a) (once-in-life unless intervened), LDL-C and -P, hs-CRP, HbA1c, fasting insulin, homocysteine, ferritin, full hormone panel, thyroid (TSH/fT4/fT3), full liver + kidney panels, omega-3 index, vitamin D 25-OH.
• Capacity tests: VO2max (annual, on treadmill or bike with mask), DEXA scan (annual — body composition + visceral fat + bone density), grip strength (anytime), gait speed, stand-from-floor.
• Decathlon performance metrics: track each event with a measurable proxy (deadlift 1RM, farmer’s carry distance × load, dead-hang time, step-up height × load, mile time).
• Continuous / episodic: 2-week CGM cycles 1-2x/year, sleep tracking (Whoop / Oura / Eight Sleep), HRV trend.

Actions (the controllable inputs)

• Cardio: ~80% Zone 2 / 20% Zone 5. Concretely: 4 × 45-60 min Zone 2/week + 1 × 30 min VO2max session/week (e.g., 4×4 protocol — 4 min near-max effort, 4 min recovery, four rounds).
• Strength: 3 × 45-60 min full-body sessions/week. Bias toward compound lifts (deadlift, squat, press, pull) and “rucking, stairs, and carries” — the load-bearing real-world patterns.
• Stability: ~1 hour/week, broken into 5-10 min blocks before other workouts. Single-leg, anti-rotation, hip mobility, foot. The pillar most adults are catastrophically weak in and the one that prevents the falls that end marginal decades.
• Sleep: non-negotiable 7.5-8.5 hours; consistent timing; cool dark room; alcohol minimized.
• Nutrition: ~1g protein per lb bodyweight; processed-food minimization; manage total calories to body composition target rather than chase any specific macro orthodoxy.
• Pharmacology (where indicated by biomarkers): lipid-lowering for elevated ApoB, rapamycin (off-label, contested), no metformin in non-diabetics if exercising hard (Attia dropped this).

Outcomes (what to optimize)

• Decathlon event metrics at age-adjusted percentile targets (e.g., VO2max in top decile for age — strong all-cause mortality predictor)
• ApoB <60 mg/dL if at meaningful CVD risk, otherwise <80
• HbA1c <5.4%
• Lean mass + visceral fat in the optimal DEXA bands
• Sleep duration + efficiency stable above target

Feedback loop

• Quarterly bloodwork → adjust supplement / pharmacology / diet
• Annual VO2max + DEXA + capacity test → adjust training program
• Decathlon event re-test every 6-12 months → check whether training is closing the gap toward the 80-year-old target

The whole system is a closed loop, with the founder as both the operator and the body being optimized.

Where Attia disagrees with Sinclair

Two quick paragraphs on the substantive differences between Attia (in this note) and the Sinclair note already in the vault at 2026-04-27-moonshots-sinclair-longevity-pill.

On supplements and “miracle molecules.” Sinclair’s stack centers on resveratrol, NMN, and metformin / berberine — molecules he has direct equity exposure to and has championed for 15+ years. Attia is publicly skeptical of NMN/NR efficacy in humans (the rodent data hasn’t translated cleanly), dropped metformin entirely after concluding the exercise-blunting effect outweighs any longevity signal in non-diabetics, and treats the whole “longevity supplement” category as low-priority compared with exercise + sleep + lipid management. Attia’s stack is biomarker-targeted (omega-3 to hit an omega-3 index target, vitamin D to a 25-OH range, magnesium for sleep) rather than mechanism-driven.

On rapamycin and the Information Theory of Aging. Inverted: Sinclair is more aggressive on epigenetic reprogramming (the OSK gene therapy bet) but rarely talks about taking rapamycin himself. Attia is the more aggressive off-label rapamycin user (8mg weekly, pulsed) and more cautious about reprogramming claims until human data lands. Net: Attia treats lifestyle + lipids as the load-bearing 80% and rapamycin as a small-but-real bet at the margin. Sinclair pushes the narrative that a small molecule will reset the system.

For Ben, Attia is the operating manual; Sinclair is the speculative bet. Run Attia’s framework day-to-day; track the Sinclair OSK trial readout in 2026 as a Sanity Check Data Dot but don’t act on it until human data arrives.

What to copy first (for Ben specifically)

Five highest-leverage, lowest-cost moves, ranked:

1. Get a full bloodwork panel at next physical. Ask for: ApoB, Lp(a) (one-time), LDL-C, LDL-P, HDL, triglycerides, hs-CRP, HbA1c, fasting insulin, homocysteine, omega-3 index, vitamin D 25-OH, ferritin, full thyroid (TSH/fT4/fT3), full CBC + CMP. Most US PCPs won’t order ApoB and Lp(a) without being asked — name them explicitly.
2. Establish a Zone 2 cardio block — 4 × 45 min/week. Heart rate target: ~70-75% of max HR, or the highest pace where you can still hold a full conversation. Bike or incline treadmill is easiest to dose. This single intervention has more outcome leverage per hour than anything else on the list.
3. Add one VO2max session/week. 4×4 protocol on the same bike or rower: 4 min as hard as you can sustain, 4 min easy recovery, four rounds. Once a week. ~30 min total. VO2max is the single best all-cause mortality predictor; most adults’ is 30-40% below where it could be.
4. Resistance training, 3x/week, biased toward Ben’s stated priorities — rucking, stairs, carries. Deadlift, weighted step-ups, farmer’s carries, weighted ruck walks, dead hangs. The “carries and stairs” pattern is exactly what Attia prescribes for the marginal-decade backsolve. 45-60 min/session.
5. Instrument with one wearable + one annual DEXA. Whoop or Oura for sleep + HRV trend. Annual DEXA for body comp + visceral fat + bone density (~$100-150 self-pay, no Rx needed).

Optional sixth: budget for one VO2max test/year at a local sports performance lab (~$150-300). It’s the test that anchors the whole training program.

Conflicts and contested ground (be honest)

Commercial conflicts to flag:

• Early Medical (his concierge longevity practice) — paid services, ~$150k+/year per patient. Most of the testing cadences in this note are tighter than insurance will cover; following Attia’s full program is a real cash outlay.
• The Drive podcast subscription tier ($199/year) gates the deepest content.
• Investor/advisor relationships disclosed in the supplement stack: Athletic Greens (AG1), Pendulum, others. Bias whenever AG1 or Pendulum probiotics show up in the stack.
• Outlive book is a commercial product; its framing is built to support paid follow-on services.

Where Attia is contested:

• Off-label rapamycin aggressiveness. Long-term human safety at 8mg/week is unproven. Rapamycin’s exercise-impairing and immunosuppressive effects are real. The longevity case is strong in mice; the human translation is a bet, not a fact.
• ApoB obsession. Some lipidologists argue the all-out ApoB-suppression stack (statin + ezetimibe + PCSK9 + bempedoic acid combined) overshoots evidence for primary-prevention patients without familial hypercholesterolemia. The marginal benefit of pushing ApoB <60 vs <80 in low-risk individuals is debated.
• Med 3.0 marketing layer. Critics note that “Medicine 3.0” rebrands established preventive cardiology + sports medicine + endocrinology as a proprietary framework. The underlying interventions are largely mainstream; the framing is the product.
• Outlive Chapter 17 (“Emotional Health”) is widely viewed as the weakest section; the quantitative rigor doesn’t carry into psychiatry.

Take the framework, take the operationalization, discount the supplement-and-services upsell, treat rapamycin as a watch-this-space rather than a copy-this.

Sources

• Peter Attia — How to Train for the Centenarian Decathlon
• Peter Attia — Training for The Centenarian Decathlon (Drive #261)
• Peter Attia — Zone 2 Topic Guide
• Peter Attia — High-intensity training (Zone 5) and VO2 max
• Peter Attia — Four horsemen of chronic disease
• Empirical Health — Four Horsemen from Outlive
• FoundMyFitness — Attia’s 80/20 Zone 2 / VO2max protocol
• FastLifeHacks — Peter Attia’s supplement list (2026)
• Petrie-Flom Center — Outlive book review (Harvard Law)
• Internal: 2026-04-27-moonshots-sinclair-longevity-pill — companion note on Sinclair’s framing for explicit contrast.